These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1726684)

  • 21. Development of antiviral agents for the treatment of human immunodeficiency virus infection.
    Tartaglione TA; Collier AC
    Clin Pharm; 1987 Dec; 6(12):927-40. PubMed ID: 3322638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection.
    Noble S; Faulds D
    Drugs; 1996 Jul; 52(1):93-112. PubMed ID: 8799687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
    Fletcher CV; Kawle SP; Kakuda TN; Anderson PL; Weller D; Bushman LR; Brundage RC; Remmel RP
    AIDS; 2000 Sep; 14(14):2137-44. PubMed ID: 11061655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects.
    Staszewski S; Katlama C; Harrer T; Massip P; Yeni P; Cutrell A; Tortell SM; Harrigan RP; Steel H; Lanier RE; Pearce G
    AIDS; 1998 Nov; 12(16):F197-202. PubMed ID: 9833847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053).
    Jacobsen MA; van der Horst C; Causey DM; Dehlinger M; Hafner R; Mills J
    J Infect Dis; 1991 Jun; 163(6):1219-22. PubMed ID: 1828075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections.
    van Rossum AM; Niesters HG; Geelen SP; Scherpbier HJ; Hartwig NG; Weemaes CM; Veerman AJ; Suur MH; de Graeff-Meeder ER; Slieker WA; Hop WC; Osterhaus AD; Burger DM; De Groot R
    J Pediatr; 2000 Jun; 136(6):780-8. PubMed ID: 10839877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoprinosine increases the antitumor action of interferon.
    Cerutti I; Chany C; Schlumberger JF
    Cancer Treat Rep; 1978 Nov; 62(11):1971-4. PubMed ID: 83190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
    Eron JJ; Yetzer ES; Ruane PJ; Becker S; Sawyer GA; Fisher RL; Tolson JM; Shaefer MS
    AIDS; 2000 Apr; 14(6):671-81. PubMed ID: 10807190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Azidothymidine in the management of immune deficiency complex].
    Bálint Gábor S
    Orv Hetil; 1993 Aug; 134(35):1921-5. PubMed ID: 8361747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
    Morin A; Griscelli C; Daguillard F
    Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes.
    Lasek W; Janyst M; Wolny R; Zapała Ł; Bocian K; Drela N
    Acta Pharm; 2015 Jun; 65(2):171-80. PubMed ID: 26011933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.
    Goodgame JC; Pottage JC; Jablonowski H; Hardy WD; Stein A; Fischl M; Morrow P; Feinberg J; Brothers CH; Vafidis I; Nacci P; Yeo J; Pedneault L
    Antivir Ther; 2000 Sep; 5(3):215-25. PubMed ID: 11075942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of isoprinosine and acyclovir on the clinical course of chickenpox and herpes zoster].
    Janeczko J; Baranowska M; Romanowska B
    Przegl Epidemiol; 1991; 45(4):267-71. PubMed ID: 1726758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.